Literature DB >> 19264275

Alternative treatments in pediatric bipolar disorder.

Mona Potter1, Alana Moses, Janet Wozniak.   

Abstract

There has been growing interest in the use of complementary and alternative treatments in pediatric bipolar disorder (BPD). There are limited data, however, regarding the safety and efficacy of these treatments. This article discusses select complementary and alternative treatments that have been considered for use in pediatric BPD and/or depression, including omega-3-fatty acids, inositol, St. John's wort, SAMe, melatonin, lecithin, and acupuncture. Background information, reference to available adult and pediatric data, proposed mechanisms of action, dosing, side effects, and precautions of these treatments are included. Across the board, more research is necessary and warranted regarding the long-term safety and efficacy of available complementary and alternative treatments for the management of pediatric BPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264275     DOI: 10.1016/j.chc.2008.11.001

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN: 1056-4993


  3 in total

1.  Neurochemical deficits in the cerebellar vermis in child offspring of parents with bipolar disorder.

Authors:  Manpreet K Singh; Daniel Spielman; Allison Libby; Elizabeth Adams; Tenah Acquaye; Meghan Howe; Ryan Kelley; Allan Reiss; Kiki D Chang
Journal:  Bipolar Disord       Date:  2011-03       Impact factor: 6.744

Review 2.  Bipolar depression in pediatric populations : epidemiology and management.

Authors:  Victoria E Cosgrove; Donna Roybal; Kiki D Chang
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

3.  Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.

Authors:  Joanne H Huang; Shaunna S Berkovitch; Jonathan Iaconelli; Bradley Watmuff; Hyoungjun Park; Shrikanta Chattopadhyay; Donna McPhie; Dost Öngür; Bruce M Cohen; Clary B Clish; Rakesh Karmacharya
Journal:  Mol Neuropsychiatry       Date:  2016-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.